Showing 1 - 10 of 122,852
This paper investigates the impact of ownership type on the entire growth rate distributional mass of Chinese firms, using a conditional estimation approach of the Asymmetric Exponential Power (AEP) density that goes beyond simple location-shift analysis. We first find a Chinese growth puzzle,...
Persistent link: https://www.econbiz.de/10010436766
This study considers the impact of macro-institutional environments, and alterations in such environments, on organizational level behavior and performance. Specifically, it examines the relationship between firm age and growth for a large sample of Indian firms. Firms are classified as falling...
Persistent link: https://www.econbiz.de/10014125257
This study considers the impact of macro-institutional environments, and alterations in such environments, on organizational level behavior and performance. Specifically, it examines the relationship between firm age and growth for a large sample of Indian firms. Firms are classified as falling...
Persistent link: https://www.econbiz.de/10014120174
, profitability, investment and growth, based on China's manufacturing firm-level dataset over the period 1998 - 2007. First, we find …
Persistent link: https://www.econbiz.de/10010500809
, profitability, investment and growth, based on China's manufacturing firm-level dataset over the period 1998-2007. First, we find …
Persistent link: https://www.econbiz.de/10011715817
Prior empirical research on US hospitals mostly concludes that ownership type – not-for-profit (NFP) versus for-profit (FP) – does not affect financial performance. This is surprising, in light of strong predictions from theories of NFP firm behavior. We revisit the issue with a...
Persistent link: https://www.econbiz.de/10011925653
This paper breaks down the distributional analysis of firm growth rates to the domain of regions. Extreme growth events, i.e. fat tails, are conceptualized as an indicator of competitive regional environments which enable processes like structural adaptation or technological re-orientation. An...
Persistent link: https://www.econbiz.de/10011303754
In drug R&D, there are big challenges today. Big pharma is struggling with a drying up of the pipeline and neglected diseases do not attract much drug development effort. India faces a different challenge not often discussed: it has not yet brought out a single widely used new drug. This is...
Persistent link: https://www.econbiz.de/10013002263
A recent report in Science states that rotaviruses (the cause of many a diarrhoea) lead to 20–60 deaths a year in the United States and about 600,000 in the developing world. This is one of the many disturbing health statistics that differentiates the developed from the developing world. If we...
Persistent link: https://www.econbiz.de/10012998208
In any assessment of the R&D capabilities of Indian companies, their patent holdings would have to be examined. Here we identify the number of patents assigned by four foreign governments to Indian pharmaceutical and biotechnological companies up to December 31, 2009. It is known that the United...
Persistent link: https://www.econbiz.de/10014130598